{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:14:21Z","timestamp":1792062861508,"version":"4.4.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T00:00:00Z","timestamp":1306800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1038\/nrrheum.2011.75","type":"journal-article","created":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T15:16:55Z","timestamp":1306855015000},"page":"399-408","source":"Crossref","is-referenced-by-count":334,"title":["Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE"],"prefix":"10.1038","volume":"7","author":[{"given":"Deborah P. M.","family":"Symmons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherine E.","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,31]]},"reference":[{"key":"BFnrrheum201175_CR1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1056\/NEJM195310012491402","volume":"249","author":"S Cobb","year":"1953","unstructured":"Cobb, S., Anderson, F. & Bauer, W. Length of life and cause of death in rheumatoid arthritis. N. Engl. J. Med. 249, 553\u2013556 (1953).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum201175_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0002-9343(76)90431-9","volume":"60","author":"MB Urowitz","year":"1976","unstructured":"Urowitz, M. B.  et al. The bimodal mortality pattern of systemic lupus erythematosus. Am. J. Med. 60, 221\u2013225 (1976).","journal-title":"Am. J. Med."},{"key":"BFnrrheum201175_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/art.1780370408","volume":"37","author":"F Wolfe","year":"1994","unstructured":"Wolfe, F.  et al. The mortality of rheumatoid arthritis. Arthritis Rheum. 37, 481\u2013494 (1994).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR4","first-page":"1072","volume":"25","author":"DP Symmons","year":"1998","unstructured":"Symmons, D. P., Jones, M. A., Scott, D. L. & Prior, P. Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J. Rheumatol. 25, 1072\u20131077 (1998).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201175_CR5","first-page":"1196","volume":"30","author":"DJ Watson","year":"2003","unstructured":"Watson, D. J., Rhodes, T. & Guess, H. A. All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J. Rheumatol. 30, 1196\u20131202 (2003).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201175_CR6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s11926-008-0063-0","volume":"10","author":"MC Wasko","year":"2008","unstructured":"Wasko, M. C. Rheumatoid arthritis and cardiovascular disease. Curr. Rheumatol. Rep. 10, 390\u2013397 (2008).","journal-title":"Curr. Rheumatol. Rep."},{"issue":"Suppl. 51","key":"BFnrrheum201175_CR7","first-page":"S35","volume":"26","author":"T Sokka","year":"2008","unstructured":"Sokka, T., Abelson, B. & Pincus, T. Mortality in rheumatoid arthritis: 2008 update. Clin. Exp. Rheumatol. 26 (Suppl. 51), S35\u2013S61 (2008).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum201175_CR8","first-page":"198","volume":"20","author":"EGL Bywaters","year":"1961","unstructured":"Bywaters, E. G. L. 10-year follow-up study of rheumatoid arthritis. Ann. Rheum. Dis. 20, 198 (1961).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201175_CR9","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/art.24092","volume":"59","author":"JA Avina-Zubieta","year":"2008","unstructured":"Avina-Zubieta, J. A.  et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 59, 1690\u20131697 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/art.20853","volume":"52","author":"H Maradit-Kremers","year":"2005","unstructured":"Maradit-Kremers, H.  et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population-based cohort study. Arthritis Rheum. 52, 402\u2013411 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR11","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1002\/art.10419","volume":"46","author":"NJ Goodson","year":"2002","unstructured":"Goodson, N. J.  et al. Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum. 46, 2010\u20132019 (2002).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR12","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/art.21204","volume":"52","author":"NJ Goodson","year":"2005","unstructured":"Goodson, N. J.  et al. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum. 52, 2293\u20132299 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/art.23402","volume":"58","author":"SM Naz","year":"2008","unstructured":"Naz, S. M., Farragher, T. M., Bunn, D. K., Symmons, D. P. & Bruce, I. N. The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis. Arthritis Rheum. 58, 985\u2013989 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/art.23149","volume":"58","author":"TM Farragher","year":"2008","unstructured":"Farragher, T. M.  et al. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum. 58, 359\u2013369 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR15","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3899\/jrheum.080322","volume":"35","author":"A Gonzalez","year":"2008","unstructured":"Gonzalez, A.  et al. Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. J. Rheumatol. 35, 1009\u20131014 (2008).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201175_CR16","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1136\/ard.2005.050377","volume":"65","author":"DH Solomon","year":"2006","unstructured":"Solomon, D. H.  et al. Patterns of cardiovascular risk in rheumatoid arthritis. Ann. Rheum. Dis. 65, 1608\u20131612 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201175_CR17","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1365-2796.2010.02260.x","volume":"268","author":"ME Holmqvist","year":"2010","unstructured":"Holmqvist, M. E.  et al. Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. J. Intern. Med. 268, 578\u2013585 (2010).","journal-title":"J. Intern. Med."},{"key":"BFnrrheum201175_CR18","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/acr.20105","volume":"62","author":"BJ Radovits","year":"2010","unstructured":"Radovits, B. J.  et al. Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis. Arthritis Care Res. (Hoboken) 62, 362\u2013370 (2010).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"BFnrrheum201175_CR19","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/rheumatology\/kep252","volume":"48","author":"C Meune","year":"2009","unstructured":"Meune, C., Touze, E., Trinquart, L. & Allanore, Y. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 48, 1309\u20131313 (2009).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201175_CR20","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1161\/01.CIR.0000142864.83780.81","volume":"110","author":"E Krishnan","year":"2004","unstructured":"Krishnan, E., Lingala, V. B. & Singh, G. Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation 110, 1774\u20131779 (2004).","journal-title":"Circulation"},{"key":"BFnrrheum201175_CR21","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1002\/art.22979","volume":"56","author":"A Gonzalez","year":"2007","unstructured":"Gonzalez, A.  et al. The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum. 56, 3583\u20133587 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3899\/jrheum.090015","volume":"36","author":"S Haque","year":"2009","unstructured":"Haque, S. & Bruce, I. N. Cardiovascular outcomes in systemic lupus erythematosus: big studies for big questions. J. Rheumatol. 36, 467\u2013469 (2009).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201175_CR23","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.3899\/jrheum.080214","volume":"35","author":"MB Urowitz","year":"2008","unstructured":"Urowitz, M. B., Gladman, D. D., Tom, B. D., Ibanez, D. & Farewell, V. T. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J. Rheumatol. 35, 2152\u20132158 (2008).","journal-title":"J. Rheumatol."},{"issue":"Suppl. 51","key":"BFnrrheum201175_CR24","first-page":"S72","volume":"26","author":"A Ippolito","year":"2008","unstructured":"Ippolito, A. & Petri, M. An update on mortality in systemic lupus erythematosus. Clin. Exp. Rheumatol. 26 (Suppl. 51), S72\u2013S79 (2008).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum201175_CR25","first-page":"36","volume":"30","author":"F Wolfe","year":"2003","unstructured":"Wolfe, F., Freundlich, B. & Straus, W. L. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J. Rheumatol. 30, 36\u201340 (2003).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201175_CR26","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","volume":"107","author":"DH Solomon","year":"2003","unstructured":"Solomon, D. H.  et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107, 1303\u20131307 (2003).","journal-title":"Circulation"},{"key":"BFnrrheum201175_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/ard.2006.052456","volume":"66","author":"A Sodergren","year":"2007","unstructured":"Sodergren, A., Stegmayr, B., Lundberg, V., Ohman, M. L. & Wallberg-Jonsson, S. Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis. Ann. Rheum. Dis. 66, 263\u2013266 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201175_CR28","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1002\/art.24855","volume":"60","author":"ME Holmqvist","year":"2009","unstructured":"Holmqvist, M. E.  et al. No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts. Arthritis Rheum. 60, 2861\u20132869 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/ard.2005.037978","volume":"65","author":"KM Douglas","year":"2006","unstructured":"Douglas, K. M.  et al. Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann. Rheum. Dis. 65, 348\u2013353 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201175_CR30","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1186\/ar3151","volume":"12","author":"S Van Doornum","year":"2010","unstructured":"Van Doornum, S., Brand, C., Sundararajan, V., Ajani, A. E. & Wicks, I. P. Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared with the general population. Arthritis Res. Ther. 12, R183 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum201175_CR31","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.amjmed.2010.05.017","volume":"123","author":"ML Francis","year":"2010","unstructured":"Francis, M. L.  et al. Outcomes in patients with rheumatoid arthritis and myocardial infarction. Am. J. Med. 123, 922\u2013928 (2010).","journal-title":"Am. J. Med."},{"key":"BFnrrheum201175_CR32","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.amjmed.2003.09.039","volume":"116","author":"F Wolfe","year":"2004","unstructured":"Wolfe, F. & Michaud, K. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Am. J. Med. 116, 305\u2013311 (2004).","journal-title":"Am. J. Med."},{"key":"BFnrrheum201175_CR33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/art.20855","volume":"52","author":"PJ Nicola","year":"2005","unstructured":"Nicola, P. J.  et al. The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years. Arthritis Rheum. 52, 412\u2013420 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR34","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1002\/art.23798","volume":"58","author":"JM Davis III","year":"2008","unstructured":"Davis, J. M. III  et al. The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum. 58, 2603\u20132611 (2008).","journal-title":"Arthritis Rheum."},{"issue":"Suppl.","key":"BFnrrheum201175_CR35","first-page":"S387","volume":"54","author":"JM Davis III","year":"2006","unstructured":"Davis, J. M. III  et al. Mortality following heart failure is higher among rheumatoid arthritis subjects compared to non-RA subjects [abstract 883]. Arthritis Rheum. 54 (Suppl.), S387 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR36","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","volume":"145","author":"S Manzi","year":"1997","unstructured":"Manzi, S.  et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am. J. Epidemiol. 145, 408\u2013415 (1997).","journal-title":"Am. J. Epidemiol."},{"key":"BFnrrheum201175_CR37","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U","volume":"42","author":"MM Ward","year":"1999","unstructured":"Ward, M. M. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum. 42, 338\u2013346 (1999).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR38","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","volume":"44","author":"JM Esdaile","year":"2001","unstructured":"Esdaile, J. M.  et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 44, 2331\u20132337 (2001).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR39","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1056\/NEJMoa035471","volume":"349","author":"MJ Roman","year":"2003","unstructured":"Roman, M. J.  et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. 349, 2399\u20132406 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum201175_CR40","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.amjcard.2003.09.037","volume":"93","author":"LM Fischer","year":"2004","unstructured":"Fischer, L. M., Schlienger, R. G., Matter, C., Jick, H. & Meier, C. R. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am. J. Cardiol. 93, 198\u2013200 (2004).","journal-title":"Am. J. Cardiol."},{"key":"BFnrrheum201175_CR41","first-page":"713","volume":"31","author":"L Bjornadal","year":"2004","unstructured":"Bjornadal, L., Yin, L., Granath, F., Klareskog, L. & Ekbom, A. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964\u20131995. J. Rheumatol. 31, 713\u2013719 (2004).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201175_CR42","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1191\/0961203305lu2200oa","volume":"14","author":"A Doria","year":"2005","unstructured":"Doria, A.  et al. Cardiac involvement in systemic lupus erythematosus. Lupus 14, 683\u2013686 (2005).","journal-title":"Lupus"},{"key":"BFnrrheum201175_CR43","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0002-9343(92)90578-Y","volume":"93","author":"M Petri","year":"1992","unstructured":"Petri, M., Perez-Gutthann, S., Spence, D. & Hochberg, M. C. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am. J. Med. 93, 513\u2013519 (1992).","journal-title":"Am. J. Med."},{"key":"BFnrrheum201175_CR44","first-page":"70","volume":"34","author":"MB Urowitz","year":"2007","unstructured":"Urowitz, M. B., Ibanez, D. & Gladman, D. D. Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J. Rheumatol. 34, 70\u201375 (2007).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201175_CR45","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/acr.20122","volume":"62","author":"MB Urowitz","year":"2010","unstructured":"Urowitz, M. B.  et al. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res. (Hoboken) 62, 881\u2013887 (2010).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"BFnrrheum201175_CR46","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/art.24537","volume":"61","author":"AE Hak","year":"2009","unstructured":"Hak, A. E., Karlson, E. W., Feskanich, D., Stampfer, M. J. & Costenbader, K. H. Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study. Arthritis Rheum. 61, 1396\u20131402 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR47","first-page":"201","volume":"1","author":"K Maksimowicz-McKinnon","year":"2008","unstructured":"Maksimowicz-McKinnon, K.  et al. Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry. Circulation 1, 201\u2013208 (2008).","journal-title":"Circulation"},{"key":"BFnrrheum201175_CR48","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3899\/jrheum.080373","volume":"36","author":"MA Shah","year":"2009","unstructured":"Shah, M. A., Shah, A. M. & Krishnan, E. Poor outcomes after acute myocardial infarction in systemic lupus erythematosus. J. Rheumatol. 36, 570\u2013575 (2009).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201175_CR49","first-page":"184","volume":"66","author":"JM Von Feldt","year":"2008","unstructured":"Von Feldt, J. M. Premature atherosclerotic cardiovascular disease and systemic lupus erythematosus from bedside to bench. Bull. NYU Hosp. Jt Dis. 66, 184\u2013187 (2008).","journal-title":"Bull. NYU Hosp. Jt Dis."},{"key":"BFnrrheum201175_CR50","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1002\/art.20556","volume":"50","author":"MM Ward","year":"2004","unstructured":"Ward, M. M. Outcomes of hospitalizations for myocardial infarctions and cerebrovascular accidents in patients with systemic lupus erythematosus. Arthritis Rheum. 50, 3170\u20133176 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR51","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"12","author":"PW Wilson","year":"1998","unstructured":"Wilson, P. W.  et al. Prediction of coronary heart disease using risk factor categories. Circulation 12, 1837\u20131847 (1998).","journal-title":"Circulation"},{"key":"BFnrrheum201175_CR52","unstructured":"British Hypertension Society. Proposed joint British societies cardiovascular disease new risk assessment charts 2009 \n                    [online]\n                    \n                   (2011)."},{"key":"BFnrrheum201175_CR53","unstructured":"Reynolds Risk Score \n                    [online]\n                    \n                   (2011)."},{"key":"BFnrrheum201175_CR54","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jbspin.2010.07.016","volume":"78","author":"JF Boyer","year":"2011","unstructured":"Boyer, J. F., Gourraud, P. A., Cantagrel, A., Davignon, J. L. & Constantin, A. Traditional cardiovascular risk factors in rheumatoid arthritis: A meta-analysis. Joint Bone Spine 78, 179\u2013183 (2011).","journal-title":"Joint Bone Spine"},{"key":"BFnrrheum201175_CR55","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1093\/rheumatology\/39.11.1202","volume":"39","author":"B Masdottir","year":"2000","unstructured":"Masdottir, B.  et al. Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis. Rheumatology (Oxford) 39, 1202\u20131205 (2000).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201175_CR56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.27758","volume":"63","author":"S Saevarsdottir","year":"2011","unstructured":"Saevarsdottir, S.  et al. Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts. Arthritis Rheum. 63, 26\u201336 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR57","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0140-6736(09)60008-8","volume":"373","author":"L Klareskog","year":"2009","unstructured":"Klareskog, L., Catrina, A. I. & Paget, S. Rheumatoid arthritis. Lancet 373, 659\u2013672 (2009).","journal-title":"Lancet"},{"key":"BFnrrheum201175_CR58","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/ard.2006.059980","volume":"67","author":"A Gonzalez","year":"2008","unstructured":"Gonzalez, A.  et al. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann. Rheum. Dis. 67, 64\u201369 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201175_CR59","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/rheumatology\/kem169","volume":"46","author":"VF Panoulas","year":"2007","unstructured":"Panoulas, V. F.  et al. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford) 46, 1477\u20131482 (2007).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201175_CR60","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jaut.2007.02.004","volume":"28","author":"BH Hahn","year":"2007","unstructured":"Hahn, B. H., Grossman, J., Chen, W. & McMahon, M. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J. Autoimmun. 28, 69\u201375 (2007).","journal-title":"J. Autoimmun."},{"key":"BFnrrheum201175_CR61","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1136\/ard.2009.126128","volume":"69","author":"AG Semb","year":"2010","unstructured":"Semb, A. G.  et al. Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. Ann. Rheum. Dis. 69, 1996\u20132001 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201175_CR62","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/ard.2009.115717","volume":"69","author":"TE Toms","year":"2010","unstructured":"Toms, T. E.  et al. Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? Ann. Rheum. Dis. 69, 683\u2013688 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201175_CR63","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.semarthrit.2008.01.015","volume":"38","author":"G Steiner","year":"2009","unstructured":"Steiner, G. & Urowitz, M. B. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin. Arthritis Rheum. 38, 372\u2013381 (2009).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrrheum201175_CR64","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/ard.2006.051672","volume":"66","author":"V van Helm","year":"2007","unstructured":"van Helm, V.  et al. Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann. Rheum. Dis. 66, 184\u2013188 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201175_CR65","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1002\/art.21976","volume":"54","author":"M McMahon","year":"2006","unstructured":"McMahon, M.  et al. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 54, 2541\u20132549 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR66","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1002\/art.22053","volume":"54","author":"PH Dessein","year":"2006","unstructured":"Dessein, P. H. & Joffe, B. I. Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis Rheum. 54, 2765\u20132775 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR67","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1001\/jama.298.2.187","volume":"11","author":"MC Wasko","year":"2007","unstructured":"Wasko, M. C.  et al. Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. JAMA 11, 187\u2013193 (2007).","journal-title":"JAMA"},{"key":"BFnrrheum201175_CR68","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/archinte.165.14.1624","volume":"165","author":"A Escalante","year":"2005","unstructured":"Escalante, A., Haas, R. W. & del Rincon, I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch. Intern. Med. 165, 1624\u20131629 (2005).","journal-title":"Arch. Intern. Med."},{"key":"BFnrrheum201175_CR69","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1002\/art.20612","volume":"50","author":"HM Maradit Kremers","year":"2004","unstructured":"Maradit Kremers, H. M., Nicola, P. J., Crowson, C. S., Ballman, K. V. & Gabriel, S. E. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum. 50, 3450\u20133457 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR70","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1136\/ard.2008.095596","volume":"68","author":"A Stavropoulos-Kalinoglou","year":"2009","unstructured":"Stavropoulos-Kalinoglou, A.  et al. Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis. Ann. Rheum. Dis. 68, 242\u2013245 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201175_CR71","first-page":"681","volume":"34","author":"PH Dessein","year":"2007","unstructured":"Dessein, P. H., Norton, G. R., Woodiwiss, A. J., Joffe, B. I. & Solomon, A. Independent role of conventional cardiovascular risk factors as predictors of C-reactive protein concentrations in rheumatoid arthritis. J. Rheumatol. 34, 681\u2013688 (2007).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201175_CR72","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/art.27376","volume":"62","author":"JT Giles","year":"2010","unstructured":"Giles, J. T.  et al. Abdominal adiposity in rheumatoid arthritis: Association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum. 62, 1259\u20131264 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR73","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1002\/art.22053","volume":"54","author":"PH Dessein","year":"2006","unstructured":"Dessein, P. H. & Joffe, B. I. Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis Rheum. 54, 2765\u20132775 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR74","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/art.23600","volume":"58","author":"C Chung","year":"2008","unstructured":"Chung, C  et al. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus Arthritis Rheum. 58, 2105\u20132112 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR75","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","volume":"108","author":"N Sattar","year":"2003","unstructured":"Sattar, N., McCarey, D. W., Capell, H. & McInnes, I. B. Explaining how 'high grade' systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108, 2957\u20132963 (2003).","journal-title":"Circulation"},{"key":"BFnrrheum201175_CR76","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/art.22689","volume":"57","author":"CA Mancuso","year":"2007","unstructured":"Mancuso, C. A., Rincon, M., Sayles, W. & Paget, S. A. Comparison of energy expenditure from lifestyle physical activities between patients with rheumatoid arthritis and healthy controls. Arthritis Rheum. 57, 672\u2013678 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR77","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1002\/art.23650","volume":"58","author":"H Maradit Kremers","year":"2008","unstructured":"Maradit Kremers, H., Crowson, C. S., Therneau, T. M., Roger, V. L. & Gabriel, S. E. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum. 58, 2268\u20132274 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR78","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.24836","volume":"61","author":"MJ Peters","year":"2009","unstructured":"Peters, M. J.  et al. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum. 61, 1571\u20131579 (2009).","journal-title":"Arthritis Rheum."},{"issue":"Suppl.","key":"BFnrrheum201175_CR79","first-page":"S264","volume":"60","author":"CS Crowson","year":"2009","unstructured":"Crowson, C. S.  et al. Does the Framingham score underestimate cardiovascular risk in rheumatoid arthritis? [abstract 706]. Arthritis Rheum. 60 (Suppl.), S264 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR80","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/ard.2009.113696","volume":"69","author":"MJ Peters","year":"2010","unstructured":"Peters, M. J.  et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann. Rheum. Dis. 69, 325\u2013331 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201175_CR81","first-page":"2562","volume":"26","author":"S Wallberg-Jonsson","year":"1999","unstructured":"Wallberg-Jonsson, S., Johansson, H., Ohman, M. L. & Rantapaa-Dahlqvist, S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J. Rheumatol. 26, 2562\u20132571 (1999).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201175_CR82","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.amjcard.2007.11.076","volume":"101","author":"S Banerjee","year":"2008","unstructured":"Banerjee, S.  et al. Cardiovascular outcomes in male veterans with rheumatoid arthritis. Am. J. Cardiol. 101, 1201\u20131205 (2008).","journal-title":"Am. J. Cardiol."},{"key":"BFnrrheum201175_CR83","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1136\/ard.2006.056390","volume":"66","author":"TM Farragher","year":"2007","unstructured":"Farragher, T. M., Lunt, M., Bunn, D. K., Silman, A. J. & Symmons, D. P. Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register. Ann. Rheum. Dis. 66, 486\u2013492 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201175_CR84","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/ard.2006.053710","volume":"66","author":"H Maradit-Kremers","year":"2007","unstructured":"Maradit-Kremers, H.  et al. Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis. Ann. Rheum. Dis. 66, 76\u201380 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201175_CR85","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.3899\/jrheum.090188","volume":"36","author":"KP Liang","year":"2009","unstructured":"Liang, K. P.  et al. Autoantibodies and the risk of cardiovascular events. J. Rheumatol. 36, 2462\u20132469 (2009).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201175_CR86","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1002\/art.23811","volume":"58","author":"F Wolfe","year":"2008","unstructured":"Wolfe, F. & Michaud, K. The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case\u2013control analysis. Arthritis Rheum. 58, 2612\u20132621 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR87","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/art.24390","volume":"61","author":"FJ Lopez-Longo","year":"2009","unstructured":"Lopez-Longo, F. J.  et al. Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Rheum. 61, 419\u2013424 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR88","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1136\/ard.2009.110536","volume":"69","author":"G Tomasson","year":"2010","unstructured":"Tomasson, G.  et al. The effect of rheumatoid factor on mortality and coronary heart disease. Ann. Rheum. Dis. 69, 1649\u20131654 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201175_CR89","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000173494","volume":"69","author":"K Aho","year":"1982","unstructured":"Aho, K., Salonen, J. T. & Puska, P. Autoantibodies predicting death due to cardiovascular disease. Cardiology 69, 125\u2013129 (1982).","journal-title":"Cardiology"},{"key":"BFnrrheum201175_CR90","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1002\/art.22255","volume":"54","author":"DH Solomon","year":"2006","unstructured":"Solomon, D. H.  et al. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum. 54, 3790\u20133798 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR91","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/ard.2007.076760","volume":"68","author":"NJ Goodson","year":"2009","unstructured":"Goodson, N. J., Brookhart, A. M., Symmons, D. P., Silman, A. J. & Solomon, D. H. Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients. Ann. Rheum. Dis. 68, 367\u2013372 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201175_CR92","doi-asserted-by":"publisher","first-page":"R30","DOI":"10.1186\/ar2383","volume":"10","author":"A Naranjo","year":"2008","unstructured":"Naranjo, A.  et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res. Ther. 10, R30 (2008).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum201175_CR93","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/art.23281","volume":"58","author":"J Listing","year":"2008","unstructured":"Listing, J.  et al. Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis? Arthritis Rheum. 58, 667\u2013677 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR94","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1136\/ard.2008.093690","volume":"68","author":"C Salliot","year":"2009","unstructured":"Salliot, C. & van der Heijde, D. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann. Rheum. Dis. 68, 1100\u20131104 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201175_CR95","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/rheumatology\/kep366","volume":"49","author":"SL Westlake","year":"2010","unstructured":"Westlake, S. L.  et al. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology (Oxford) 49, 295\u2013307 (2010).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201175_CR96","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1517\/14656566.9.7.1121","volume":"9","author":"J Avouac","year":"2008","unstructured":"Avouac, J. & Allanore, Y. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs. Expert Opin. Pharmacother. 9, 1121\u20131128 (2008).","journal-title":"Expert Opin. Pharmacother."},{"key":"BFnrrheum201175_CR97","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","volume":"363","author":"DW McCarey","year":"2004","unstructured":"McCarey, D. W.  et al. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet 363, 2015\u20132021 (2004).","journal-title":"Lancet"},{"key":"BFnrrheum201175_CR98","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1002\/art.11296","volume":"48","author":"IN Bruce","year":"2003","unstructured":"Bruce, I. N., Urowitz, M. B., Gladman, D. D., Ibanez, D. & Steiner, G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. Arthritis Rheum. 48, 3159\u20133167 (2003).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR99","first-page":"1545","volume":"33","author":"K-E Sada","year":"2006","unstructured":"Sada, K.-E.  et al. Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J. Rheumatol. 33, 1545\u20131552 (2006).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201175_CR100","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/art.23353","volume":"59","author":"MB Urowitz","year":"2008","unstructured":"Urowitz, M. B.  et al. Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum. 59, 176\u2013180 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201175_CR101","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1191\/096120300669204787","volume":"9","author":"P Rahman","year":"2000","unstructured":"Rahman, P., Aguero, S., Gladman, D. D., Hallett, D. & Urowitz, M. B. Vascular events in hypertensive patients with systemic lupus erythematosus. Lupus 9, 672\u2013675 (2000).","journal-title":"Lupus"},{"key":"BFnrrheum201175_CR102","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1093\/rheumatology\/kei142","volume":"44","author":"IN Bruce","year":"2005","unstructured":"Bruce, I. N. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology (Oxford) 44, 1492\u20131502 (2005).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201175_CR103","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1161\/01.STR.0000254476.05620.14","volume":"38","author":"J Mikdashi","year":"2007","unstructured":"Mikdashi, J., Handwerger, B., Langenberg, P., Miller, M. & Kittner, S. Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus. Stroke 38, 281\u2013285 (2007).","journal-title":"Stroke"},{"key":"BFnrrheum201175_CR104","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/MOL.0b013e328304b65f","volume":"19","author":"S Haque","year":"2008","unstructured":"Haque, S., Mirjafari, H. & Bruce, I. N. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Curr. Opin. Lipidol. 19, 338\u2013343 (2008).","journal-title":"Curr. Opin. Lipidol."},{"key":"BFnrrheum201175_CR105","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/ard.2006.068676","volume":"66","author":"GS Alarcon","year":"2007","unstructured":"Alarcon, G. S.  et al. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann. Rheum. Dis. 66, 1168\u20131172 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201175_CR106","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1002\/art.20622","volume":"50","author":"SM Toloza","year":"2004","unstructured":"Toloza, S. M.  et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum. 50, 3947\u20133957 (2004).","journal-title":"Arthritis Rheum."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2011.75.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2011.75","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2011.75.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:29:35Z","timestamp":1684470575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2011.75"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,31]]},"references-count":106,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["BFnrrheum201175"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2011.75","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,31]]}}}